IP Library Granted Patent US 10,350,171
Granted Patent B2
US 10,350,171 · App. 16/008,538 · Granted Jul 16, 2019

Celecoxib and amlodipine formulation and method of making the same

Inventor: Yitshak Itsik Efrati (Modiin, IL)
Assignees: Dexcel Ltd.; Kitov Pharmaceuticals
A61K9/2077A61K9/5084A61K31/415A61K47/02A61K47/10A61K47/12A61K47/18A61K47/26A61K47/32A61K47/38A61K47/44A61K31/4422A61K2300/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,350,171
App. No.
16/008,538
Granted
Jul 16, 2019
Kind
B2
Abstract

Provided herein is a celecoxib and amlodipine composition and method of making the same. The composition contains granules containing celecoxib. The amlodipine is incorporated into the composition as an extragranulate.

Claims (13)

1. A method of preparing a pharmaceutical composition comprising celecoxib and amlodipine or pharmaceutically acceptable salts thereof, the method comprising the steps of:

(i) wet granulating celecoxib or a pharmaceutically acceptable salt thereof and one or more excipients to obtain a wet granulate, wherein said wet granulate does not include amlodipine;

(ii) drying the wet granulate of step (i) to obtain a dry granulate having a loss on drying (LOD) % of about 2.5% or less; and

(iii) admixing the dry granulate of step (ii) with an extragranulate comprising amlodipine or a pharmaceutically acceptable salt thereof and optionally one or more excipients.

2. The method of claim 1 , wherein the dry granulate has LOD % in the range of from about 0.5% to about 2%.

3. The method of claim 2 , wherein the dry granulate has LOD % in the range of from about 0.5% to about 1.5%.

4. The method of claim 1 , wherein step (i) comprises dry mixing celecoxib or a pharmaceutically acceptable salt thereof and one or more excipients to obtain a dry mixture, and spraying the dry mixture with a granulation solution or suspension to obtain a wet granulate.

5. The method of claim 4 , wherein the granulation solution or suspension comprises an aqueous medium.

6. The method of claim 4 , wherein the granulation solution or suspension comprises an organic medium.

7. The method of claim 1 , wherein the extragranulate in step (iii) comprises one or more excipients, and wherein the one or more excipients in the wet granulate of step (i) and the one or more excipients in the extragranulate of step (iii) are the same or different selected from the group consisting of a diluent, a disintegrant, a surfactant, a binder, a glidant, a lubricant, and combinations thereof.

8. The method of claim 1 further comprising a step of milling the dry granulate of step (ii) to produce a milled dry granulate prior to step (iii).

9. The method of claim 1 , further comprising a step of compressing the phamiaceutical composition to obtain a tablet or a caplet.

10. A pharmaceutical composition prepared by the method of claim 1 .

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE ADDRESS PREVIOUSLY RECORDED AT REEL: 061885 FRAME: 0720. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Dec 5, 2022
From: KITOV PHARMA LTD
To: PURPLE BIOTECH LTD
Reel/Frame 062056/0778 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 7, 2022
From: PURPLE BIOTECH LTD
To: DEXCEL LTD.
Reel/Frame 061673/0876 →
CHANGE OF NAME Recorded Nov 7, 2022
From: KITOV PHARMA LTD
To: PURPLE BIOTECH LTD
Reel/Frame 061885/0720 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 7, 2021
From: DEXCEL LTD.
To: DEXCEL LTD.; KITOV PHARMACEUTICALS LTD.
Reel/Frame 056165/0237 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 6, 2021
From: EFRATI, YITSHAK ITSIK
To: DEXCEL LTD.
Reel/Frame 056151/0933 →
Continuity (2)
Provisional Application 62529061 · Jul 6, 2017
Related Publication 20190008777A1 · Jan 10, 2019